Arcus Biosciences Inc (RCUS)
17.10
+0.66
(+3.98%)
USD |
NYSE |
Dec 04, 16:00
17.10
0.00 (0.00%)
After-Hours: 20:00
Arcus Biosciences Max Drawdown (5Y): 72.29% for Nov. 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
November 30, 2024 | 72.29% |
October 31, 2024 | 72.29% |
September 30, 2024 | 72.29% |
August 31, 2024 | 72.29% |
July 31, 2024 | 72.29% |
June 30, 2024 | 72.29% |
May 31, 2024 | 72.29% |
April 30, 2024 | 72.29% |
March 31, 2024 | 72.29% |
February 29, 2024 | 72.29% |
January 31, 2024 | 72.29% |
December 31, 2023 | 72.29% |
November 30, 2023 | 72.29% |
October 31, 2023 | 70.44% |
September 30, 2023 | 67.07% |
August 31, 2023 | 67.07% |
July 31, 2023 | 67.07% |
June 30, 2023 | 67.07% |
May 31, 2023 | 67.07% |
April 30, 2023 | 67.07% |
March 31, 2023 | 67.07% |
February 28, 2023 | 64.45% |
January 31, 2023 | 64.45% |
December 31, 2022 | 64.45% |
November 30, 2022 | 64.45% |
Date | Value |
---|---|
October 31, 2022 | 64.45% |
September 30, 2022 | 64.45% |
August 31, 2022 | 64.45% |
July 31, 2022 | 64.45% |
June 30, 2022 | 64.45% |
May 31, 2022 | 64.45% |
April 30, 2022 | 63.64% |
March 31, 2022 | 63.64% |
February 28, 2022 | 63.64% |
January 31, 2022 | 63.64% |
December 31, 2021 | 63.64% |
November 30, 2021 | 63.64% |
October 31, 2021 | 63.64% |
September 30, 2021 | 63.64% |
August 31, 2021 | 63.64% |
July 31, 2021 | 63.64% |
June 30, 2021 | 63.64% |
May 31, 2021 | 63.64% |
April 30, 2021 | 63.64% |
March 31, 2021 | 63.64% |
February 28, 2021 | 63.64% |
January 31, 2021 | 63.64% |
December 31, 2020 | 63.64% |
November 30, 2020 | 63.64% |
October 31, 2020 | 63.64% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
63.64%
Minimum
Dec 2019
72.29%
Maximum
Nov 2023
66.16%
Average
64.45%
Median
May 2022
Max Drawdown (5Y) Benchmarks
Merck & Co Inc | 27.26% |
Regeneron Pharmaceuticals Inc | 43.25% |
NovaBay Pharmaceuticals Inc | 99.98% |
Palatin Technologies Inc | 97.38% |
iBio Inc | 99.97% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -0.8215 |
Beta (5Y) | 0.8769 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 84.86% |
Historical Sharpe Ratio (5Y) | 0.1283 |
Historical Sortino (5Y) | 0.3225 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 27.14% |